Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 4, 2008, Pages 469-477

  Liu, Daihong ^a   Huang, Xiaojun ^a   Liu, Kaiyan ^a   Xu, Lanping ^a   Chen, Huan ^a   Han, Wei ^a   Chen, Yuhong ^a   Zhang, Xiaohui ^a   Jiang, Qian ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

children; haploidentical; hematological malignancies; hematopoietic stem cell transplantation

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; ARABINOSIDE; AZATHIOPRINE; BUSULFAN; CASPOFUNGIN; CEFEPIME; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; FLUCONAZOLE; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; ITRACONAZOLE; MEROPENEM; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PIPERACILLIN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEMUSTINE; TACROLIMUS; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CANDIDIASIS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DONOR; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HERPES ZOSTER; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IN VITRO STUDY; INCIDENCE; MALE; MONOTHERAPY; MYCOSIS; PNEUMOCYSTOSIS; PROBABILITY; SAFETY; T CELL DEPLETION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; FOLLOW-UP STUDIES; GANCICLOVIR; GRAFT VS HOST DISEASE; HAPLOIDY; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; TRANSPLANTATION CONDITIONING;

EID: 40649100097     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.02.007     Document Type: Article

References (20)

1. Woods W.G., Neudorf S., Gold S., et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 97 (2001) 56-62
2. Kersey J.H. Fifty years of studies of the biology and therapy of childhood leukemia. Blood 90 (1997) 4243-4251
3. Thomson B.G., Robertson K.A., Gowan D., et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 96 (2000) 2703-2711
4. Mary E., Pablo R., Mei-jie Z., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Lancet 369 (2007) 1947-1954
5. Lu D.P., Dong L., Wu T., et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107 (2006) 3065-3073
6. Huang X.J., Liu D.H., Liu K.Y., et al. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant 38 (2006) 291-297
7. Liu Y., Chen S., and Yu H. Standardization and quality control in flow cytometric enumeration of CD34(+) cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 8 (2000) 302-306
8. Keith M.S. Graft-vs.-Host Disease. Thomas' Hematopoietic cell transplantation. Third Edition. Section 4, 50:635-664.
9. Huang X.J., Jiang Q., Chen H., et al. Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 36 (2005) 343-348
10. Rocha V., Cornish J., Sievers E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97 (2001) 2962-2971
11. Pui C.H., Sandlund J.T., Pei D., et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104 (2004) 2690-2696
12. Silverman L.B., Gelber R.D., Dalton V.K., et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97 (2001) 1211-1218
13. Satwani P., Sather H., Ozkaynak F., et al. Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: A children's oncology group study report. Biol Blood Marrow Transplant 13 (2007) 218-227
14. Gaynon P.S., Harris R.E., Altman A.J., et al. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 mos of the completion of primary therapy: Children's Oncology Group study CCG-1941. J Clin Oncol 24 (2006) 3150-3156
15. Waller E.K., Langston A.A., Lonial S., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 9 (2003) 460-471
16. Marks D.I., Aversa F., and Lazarus H.M. Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the 3 major options. Bone Marrow Transplant 38 (2006) 467-475
17. Rizzieri D.A., Koh L.P., Long G.D., et al. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. J Clin Oncol 25 (2007) 690-697
18. Chen X., Hale G.A., Barfield R., et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a Cd3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 135 (2006) 524-532
19. Oliansky D.M., Rizzo J.D., Aplan P.D., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 13 (2007) 1-25
20. Children's Oncology Group, Aplenc R., Alonzo T.A., Gerbing R.B., et al. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group. Blood 108 (2006) 74-80